AilseBio
Pre-clinicalAilseBio is developing innovative immunotherapies powered by its proprietary TiNADiscovery platform. A ground breaking class of Therapy Induced Novel Antigens with unique features, representing a new frontier for Immunotherapy
Founded
2021
Focus
Vaccines
About
AilseBio is developing innovative immunotherapies powered by its proprietary TiNADiscovery platform. A ground breaking class of Therapy Induced Novel Antigens with unique features, representing a new frontier for Immunotherapy
Funding History
1Total raised: $1.8M
Seed$1.8MUndisclosedMay 15, 2020
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile